Hopff, Sina M.
Appel, Katharina S.
Miljukov, Olga
Schneider, Johannes
Addo, Marylyn M.
Bals, Robert
Bercker, Sven
Blaschke, Sabine
Bröhl, Isabel
Büchner, Nikolaus
Dashti, Hiwa
Erber, Johanna
Friedrichs, Anette
Geisler, Ramsia
Göpel, Siri
Hagen, Marina
Hanses, Frank
Jensen, Björn-Erik Ole
Keul, Maria
Krawczyk, Adalbert
Lorenz-Depiereux, Bettina
Meybohm, Patrick
Milovanovic, Milena
Mitrov, Lazar
Nürnberger, Carolin
Obst, Wilfried
Römmele, Christoph
Schäfer, Christian
Scheer, Christian
Scherer, Margarete
Schmidt, Julia
Seibel, Kristina
Sikdar, Shimita
Tebbe, Johannes Josef
Tepasse, Phil-Robin
Thelen, Philipp
Vehreschild, Maria J. G. T.
Weismantel, Christina
Vehreschild, J. Janne
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 8 January 2024
Accepted: 13 April 2024
First Online: 3 May 2024
Declarations
:
: The authors declare no competing interests.
: The authors have no competing interests to declare that are relevant to the content of this article.
: This study was performed in line with the principles of the Declaration of Helsinki. For the NAPKON-SUEP, a primary ethics vote was obtained at the Ethics Committee of the Department of Medicine at Goethe University Frankfurt (local ethics ID approval 20-924). All further study sites received their local ethics votes at the respective ethics commissions. The NAPKON-SUEP is registered at ClinicalTrials.gov (Identifier: NCT04768998). Approval for this study was granted by the Ethics Committee of the Department of Medicine at Goethe University Frankfurt (local ethics ID approval 2021-350).
: Written informed consent was obtained from all individual participants included in the study.